HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A multicentre randomised placebo-controlled double-blind study on adjuvant treatment of mediastinitis with immunoglobulins (Pentaglobin) after cardiac surgery (ATMI): outline and preliminary study protocol for discussion. The ATMI Study Group.

Abstract
We present the second draft of a consensus-assisted protocol on the adjuvant treatment after cardiac surgery with immunoglobulins of mediastinitis. CLINICAL PHASE: Phase III.
OBJECTIVE OF THE STUDY:
Placebo-controlled investigation of the clinical efficacy of Pentaglobin (Biotest, Germany) as an added treatment in patients with mediastinitis.
MEDICATION:
Group A, active Pentaglobin; Group B, placebo: 5% glucose solution with 1% human albumin.
DOSAGE:
5 ml/kg body weight Pentaglobulin or placebo intravenously each day for 5 days.
STUDY DESIGN:
Prospective, placebo-controlled, double blind, randomised, multicentre.
SAMPLE SIZE:
n = 100; 50 patients with Pentaglobin (active), 50 patients with placebo.
PRIMARY OUTCOME MEASURE:
Cumulative therapeutic intervention scoring system (TISS-28) during hospital stay.
AuthorsG Marggraf, E A Neugebauer
JournalThe European journal of surgery. Supplement. : = Acta chirurgica. Supplement (Eur J Surg Suppl) Issue 584 Pg. 26-32 ( 1999) ISSN: 1102-416X [Print] England
PMID10890228 (Publication Type: Clinical Trial, Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Immunoglobulin A
  • Immunoglobulin M
  • Immunoglobulins, Intravenous
  • Placebos
  • pentaglobulin
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Cardiac Surgical Procedures (adverse effects)
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Immunoglobulin A (therapeutic use)
  • Immunoglobulin M (therapeutic use)
  • Immunoglobulins, Intravenous (therapeutic use)
  • Mediastinitis (therapy)
  • Patient Selection
  • Placebos
  • Prospective Studies
  • Research Design
  • Sample Size
  • Sepsis (therapy)
  • Surgical Wound Dehiscence (therapy)
  • Surgical Wound Infection (therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: